You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Beyfortus for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants.